The Argenta website uses cookies to store information on your computer, to improve our website. One of the cookies we use is essential for parts of the site to operate and has already been set. You may delete and block all cookies from this site, but parts of the site will not work. To find out more about the cookies we use and how to delete them, see our privacy notice.

I accept cookies from this site
 

In this section...

CADD

CADD

Argenta's CADD group comprises highly experienced molecular modellers and is directed by Dr David Clark. The group offers the full complement of CADD capabilities such as ligand- and structure-based drug design, protein modelling and QSAR, including predictive/in silico ADMET. We utilise a comprehensive range of industry standard software combined with computational approaches developed in-house.

For more information on our CADD capabilities please contact us.


Print to HTML

Innovation. Expertise. Delivered